91大神

Clinical Trial</h3>\r\n<p><b>Offered by:</b> 91大神&nbsp;Children's<br>\r\n<b>Locations: </b>Delaware Valley and Jacksonville in Florida</p>\r\n<h3>Trial Name</h3>\r\n<p>Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor</p>\r\n<h3>What is the trial about?<br>\r\n</h3>\r\n<p>Compares the effects (good and/or bad) of a medicine called modafinil to a placebo (no active medicine).</p>\r\n<h3>Who can participate?<br>\r\n</h3>\r\n<p>Patients who have been treated for a primary brain tumor with surgery, chemotherapy and/or radiation therapy.</p>\r\n<h3>What is involved?</h3>\r\n<ul>\r\n<li>The study will last a maximum of 10 weeks.&nbsp;</li>\r\n<li>Your child will take modafinil or placebo daily for 6 weeks. Then he/she will repeat tests that were given before starting study medicine.</li>\r\n<li>30 days later the study staff will see how he/she is doing.</li>\r\n</ul>\r\n"}} id=text-e1429a0d78 class=cmp-text>

Clinical Trial

Offered by: 91大神听Children's
Locations: Delaware Valley and Jacksonville in Florida

Trial Name

Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor

What is the trial about?

Compares the effects (good and/or bad) of a medicine called modafinil to a placebo (no active medicine).

Who can participate?

Patients who have been treated for a primary brain tumor with surgery, chemotherapy and/or radiation therapy.

What is involved?

• The study will last a maximum of 10 weeks.听
• Your child will take modafinil or placebo daily for 6 weeks. Then he/she will repeat tests that were given before starting study medicine.
• 30 days later the study staff will see how he/she is doing.

<strong>Trial Name: </strong>Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor<br>\r\n<strong>IRB#:</strong> ACCL0922</p>\r\n"}} id=text-b0fd05f57a class=cmp-text>

Trial Name: Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor
IRB#: ACCL0922